Drawing similarities between how the immune system reacts to lung cancer and HIV could uncover potential new drug targets.
In this week’s news a drug was approved for some lung cancer patients in England, and vaping could be a big piece of the quitting smoking puzzle.
A year on from a big data report and some hospitals have changed how they discuss some aspects of treatment, including palliative care.
Researchers believe that focused high doses of radiotherapy could one day replace surgery for small cancers in certain organs.
New research by our scientists may have identified a new way to predict which patients might benefit from certain immunotherapies, and those who likely won’t.
Targeted treatment up front improves survival for advanced prostate cancer, and we predict a change in thinking for precision cancer medicine.
We speak to Jane Hair, a biobanker involved in the National Lung Matrix Trial, about what her job involves.
We speak to Amanda Watson, research nurse on the National Lung Matrix Trial, about what her job involves.
We speak to Susie Brown, Trial Coordinator on the National Lung Matrix Trial, about what her job involves.